Lethal myocardial reperfusion injury: A necessary evil?

International Journal of Cardiology

Volumn 151, Issue 1, 2011, Pages 3-11

  Ibanez, Borja ^a,b   Fuster, Valentin ^a,c   Jiménez Borreguero, Jesús ^a   Badimon, Juan J ^c  

^a CENTRO NACIONAL DE INVESTIGACIONES CARDIOVASCULARES CNIC   (Spain)

^b UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

^c MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

Adrenergic receptors; Beta blockers; Cardioprotection; Ischemia reperfusion; Myocardial infarction; Myocardial salvage; Reperfusion injury

Indexed keywords

ADENOSINE; ATRIAL NATRIURETIC FACTOR; BRAIN NATRIURETIC PEPTIDE; CALCIUM ION; CALDARET; CARDIOVASCULAR AGENT; CARVEDILOL; CASPASE INHIBITOR; CONNEXIN 43; CYCLOSPORIN; CYCLOSPORIN A; ENDOTHELIAL NITRIC OXIDE SYNTHASE; ENIPORIDE; GLUCOSE; INDUCIBLE NITRIC OXIDE SYNTHASE; INSULIN; IVABRADINE; MC 135; METOPROLOL; NEURONAL NITRIC OXIDE SYNTHASE; OXYGEN; PEXELIZUMAB; PLACEBO; POTASSIUM; PROTEIN KINASE C DELTA INHIBITOR; PROTEIN KINASE C INHIBITOR; RHO KINASE; STAT3 PROTEIN; UNCLASSIFIED DRUG; UNINDEXED DRUG; VASCULAR ENDOTHELIAL CADHERIN;

ABSENCE OF SIDE EFFECTS; ACUTE HEART INFARCTION; ANTIINFLAMMATORY ACTIVITY; APOPTOSIS; CARDIOVASCULAR DISEASE; CELL PH; HEART INFARCTION; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HYPERGLYCEMIA; HYPERKALEMIA; MITOCHONDRIAL PERMEABILITY; MULTICENTER STUDY (TOPIC); NONHUMAN; OXIDATIVE STRESS; OXYGEN THERAPY; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; PROTEIN DEPHOSPHORYLATION; PROTEIN PHOSPHORYLATION; PROTEIN SYNTHESIS INHIBITION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REPERFUSION INJURY; REVIEW; SINGLE DRUG DOSE; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

ANIMALS; HUMANS; MYOCARDIAL INFARCTION; MYOCARDIAL REPERFUSION; MYOCARDIAL REPERFUSION INJURY;

EID: 79961172205     PISSN: 01675273     EISSN: 18741754     Source Type: Journal    
DOI: 10.1016/j.ijcard.2010.10.056     Document Type: Review

References (138)

1. Jennings R.B., and Reimer K.A. Factors involved in salvaging ischemic myocardium: effect of reperfusion of arterial blood Circulation 68 1983 I25 I36
2. Reimer K.A., Lowe J.E., Rasmussen M.M., and Jennings R.B. The wavefront phenomenon of ischemic cell death. 1. Myocardial infarct size vs duration of coronary occlusion in dogs Circulation 56 1977 786 794 (Pubitemid 8235183)
3. Roberts R., and Kleiman N.S. Earlier diagnosis and treatment of acute myocardial infarction necessitates the need for a "new diagnostic mind-set" Circulation 89 1994 872 881 (Pubitemid 24056217)
4. Kloner R.A., and Rezkalla S.H. Cardiac protection during acute myocardial infarction: where do we stand in 2004? J Am Coll Cardiol 44 2004 276 286 (Pubitemid 38950583)
5. Braunwald E., and Kloner R.A. Myocardial reperfusion: a double-edged sword? J Clin Invest 76 1985 1713 1719 (Pubitemid 16196036)
6. Kloner R.A. Does reperfusion injury exist in humans? J Am Coll Cardiol 21 1993 537 545 (Pubitemid 23047942)
7. Zhao Z.Q., Morris C.D., and Budde J.M. Inhibition of myocardial apoptosis reduces infarct size and improves regional contractile dysfunction during reperfusion Cardiovasc Res 59 2003 132 142 (Pubitemid 36776379)
8. Zhao Z.Q., Corvera J.S., and Halkos M.E. Inhibition of myocardial injury by ischemic postconditioning during reperfusion: comparison with ischemic preconditioning Am J Physiol Heart Circ Physiol 285 2003 H579 H588
9. Piper H.M., Garcia-Dorado D., and Ovize M. A fresh look at reperfusion injury Cardiovasc Res 38 1998 291 300 (Pubitemid 28294147)
10. Yellon D.M., and Baxter G.F. Reperfusion injury revisited: is there a role for growth factor signaling in limiting lethal reperfusion injury? Trends Cardiovasc Med 9 1999 245 249
11. Gottlieb R.A., Burleson K.O., Kloner R.A., Babior B.M., and Engler R.L. Reperfusion injury induces apoptosis in rabbit cardiomyocytes J Clin Invest 94 1994 1621 1628 (Pubitemid 24309885)
12. Yellon D.M., and Hausenloy D.J. Myocardial reperfusion injury N Engl J Med 357 2007 1121 1135
13. Prasad A., Stone G.W., Holmes D.R., and Gersh B. Reperfusion injury, microvascular dysfunction, and cardioprotection: the "dark side" of reperfusion Circulation 120 2009 2105 2112
14. Schafer C., Ladilov Y., and Inserte J. Role of the reverse mode of the Na+/Ca2+ exchanger in reoxygenation-induced cardiomyocyte injury Cardiovasc Res 51 2001 241 250 (Pubitemid 32695534)
15. Rodriguez-Sinovas A., Abdallah Y., Piper H.M., and Garcia-Dorado D. Reperfusion injury as a therapeutic challenge in patients with acute myocardial infarction Heart Fail Rev 12 2007 207 216 (Pubitemid 350176694)
16. Klein H.H., Pich S., Lindert S., Nebendahl K., Warneke G., and Kreuzer H. Treatment of reperfusion injury with intracoronary calcium channel antagonists and reduced coronary free calcium concentration in regionally ischemic, reperfused porcine hearts J Am Coll Cardiol 13 1989 1395 1401
17. Gumina R.J., Buerger E., Eickmeier C., Moore J., Daemmgen J., and Gross G.J. Inhibition of the Na(+)/H(+) exchanger confers greater cardioprotection against 90 minutes of myocardial ischemia than ischemic preconditioning in dogs Circulation 100 1999 2519 2526 discussion 469-472 (Pubitemid 30005116)
18. Zeymer U., Suryapranata H., and Monassier J.P. The Na(+)/H(+) exchange inhibitor eniporide as an adjunct to early reperfusion therapy for acute myocardial infarction. Results of the evaluation of the safety and cardioprotective effects of eniporide in acute myocardial infarction (ESCAMI) trial J Am Coll Cardiol 38 2001 1644 1650 (Pubitemid 33065449)
19. Bar F.W., Tzivoni D., and Dirksen M.T. Results of the first clinical study of adjunctive CAldaret (MCC-135) in patients undergoing primary percutaneous coronary intervention for ST-elevation myocardial infarction: the randomized multicentre CASTEMI study Eur Heart J 27 2006 2516 2523 (Pubitemid 44627293)
20. Avkiran M., and Marber M.S. Na(+)/H(+) exchange inhibitors for cardioprotective therapy: progress, problems and prospects J Am Coll Cardiol 39 2002 747 753 (Pubitemid 34185318)
21. Garcia-Dorado D., Inserte J., and Ruiz-Meana M. Gap junction uncoupler heptanol prevents cell-to-cell progression of hypercontracture and limits necrosis during myocardial reperfusion Circulation 96 1997 3579 3586 (Pubitemid 27513436)
22. Schulz R., Gres P., and Skyschally A. Ischemic preconditioning preserves connexin 43 phosphorylation during sustained ischemia in pig hearts in vivo FASEB J 17 2003 1355 1357
23. Garcia-Dorado D., Ruiz-Meana M., Padilla F., Rodriguez-Sinovas A., and Mirabet M. Gap junction-mediated intercellular communication in ischemic preconditioning Cardiovasc Res 55 2002 456 465 (Pubitemid 34874940)
24. Zweier J.L., and Talukder M.A. The role of oxidants and free radicals in reperfusion injury Cardiovasc Res 70 2006 181 190
25. Chambers D.E., Parks D.A., and Patterson G. Xanthine oxidase as a source of free radical damage in myocardial ischemia J Mol Cell Cardiol 17 1985 145 152 (Pubitemid 16241099)
26. Uraizee A., Reimer K.A., Murry C.E., and Jennings R.B. Failure of superoxide dismutase to limit size of myocardial infarction after 40 minutes of ischemia and 4 days of reperfusion in dogs Circulation 75 1987 1237 1248 (Pubitemid 17081033)
27. Ishii H., Ichimiya S., and Kanashiro M. Impact of a single intravenous administration of nicorandil before reperfusion in patients with ST-segment-elevation myocardial infarction Circulation 112 2005 1284 1288 (Pubitemid 41266722)
28. Kitakaze M., Asakura M., and Kim J. Human atrial natriuretic peptide and nicorandil as adjuncts to reperfusion treatment for acute myocardial infarction (J-WIND): two randomised trials Lancet 370 2007 1483 1493 (Pubitemid 47625560)
29. Chung H.T., Pae H.O., Choi B.M., Billiar T.R., and Kim Y.M. Nitric oxide as a bioregulator of apoptosis Biochem Biophys Res Commun 282 2001 1075 1079
30. Liang F., Gao E., and Tao L. Critical timing of l-arginine treatment in post-ischemic myocardial apoptosis-role of NOS isoforms Cardiovasc Res 62 2004 568 577 (Pubitemid 38648971)
31. Garcia-Dorado D., Rodriguez-Sinovas A., Ruiz-Meana M., Inserte J., Agullo L., and Cabestrero A. The end-effectors of preconditioning protection against myocardial cell death secondary to ischemia-reperfusion Cardiovasc Res 70 2006 274 285
32. Ladilov Y.V., Siegmund B., and Piper H.M. Protection of reoxygenated cardiomyocytes against hypercontracture by inhibition of Na+/H + exchange Am J Physiol 268 1995 H1531 H1539
33. Kim J.S., Jin Y., and Lemasters J.J. Reactive oxygen species, but not Ca2+ overloading, trigger pH- and mitochondrial permeability transition-dependent death of adult rat myocytes after ischemia-reperfusion Am J Physiol Heart Circ Physiol 290 2006 H2024 H2034
34. Ruiz-Meana M., Pina P., and Garcia-Dorado D. Glycine protects cardiomyocytes against lethal reoxygenation injury by inhibiting mitochondrial permeability transition J Physiol 558 2004 873 882 (Pubitemid 39199110)
35. Bond J.M., Herman B., and Lemasters J.J. Protection by acidotic pH against anoxia/reoxygenation injury to rat neonatal cardiac myocytes Biochem Biophys Res Commun 179 1991 798 803
36. Staat P., Rioufol G., and Piot C. Postconditioning the human heart Circulation 112 2005 2143 2148 (Pubitemid 41475808)
37. Frangogiannis N.G., Smith C.W., and Entman M.L. The inflammatory response in myocardial infarction Cardiovasc Res 53 2002 31 47 (Pubitemid 34020764)
38. Vedder N.B., Winn R.K., Rice C.L., Chi E.Y., Arfors K.E., and Harlan J.M. Inhibition of leukocyte adherence by anti-CD18 monoclonal antibody attenuates reperfusion injury in the rabbit ear Proc Natl Acad Sci USA 87 1990 2643 2646
39. Daemen M.A., van 't Veer C., and Denecker G. Inhibition of apoptosis induced by ischemia-reperfusion prevents inflammation J Clin Invest 104 1999 541 549
40. Dejana E. Endothelial adherens junctions: implications in the control of vascular permeability and angiogenesis J Clin Invest 98 1996 1949 1953 (Pubitemid 26376280)
41. Petzelbauer P., Zacharowski P.A., and Miyazaki Y. The fibrin-derived peptide Bbeta15-42 protects the myocardium against ischemia-reperfusion injury Nat Med 11 2005 298 304 (Pubitemid 40460558)
42. Atar D., Petzelbauer P., and Schwitter J. Effect of intravenous FX06 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction results of the F.I.R.E. (Efficacy of FX06 in the Prevention of Myocardial Reperfusion Injury) trial J Am Coll Cardiol 53 2009 720 729
43. Armstrong P.W., Granger C.B., and Adams P.X. Pexelizumab for acute ST-elevation myocardial infarction in patients undergoing primary percutaneous coronary intervention: a randomized controlled trial Jama 297 2007 43 51 (Pubitemid 46041725)
44. Hausenloy D.J., and Yellon D.M. The mitochondrial permeability transition pore: its fundamental role in mediating cell death during ischaemia and reperfusion J Mol Cell Cardiol 35 2003 339 341 (Pubitemid 36411694)
45. Javadov S., and Karmazyn M. Mitochondrial permeability transition pore opening as an endpoint to initiate cell death and as a putative target for cardioprotection Cell Physiol Biochem 20 2007 1 22 (Pubitemid 46956808)
46. Piper H.M., Abdallah Y., and Schafer C. The first minutes of reperfusion: a window of opportunity for cardioprotection Cardiovasc Res 61 2004 365 371 (Pubitemid 38210144)
47. Griffiths E.J., and Halestrap A.P. Mitochondrial non-specific pores remain closed during cardiac ischaemia, but open upon reperfusion Biochem J 307 Pt 1 1995 93 98
48. Argaud L., Gateau-Roesch O., and Chalabreysse L. Preconditioning delays Ca2 + -induced mitochondrial permeability transition Cardiovasc Res 61 2004 115 122 (Pubitemid 38056687)
49. Argaud L., Gateau-Roesch O., Raisky O., Loufouat J., Robert D., and Ovize M. Postconditioning inhibits mitochondrial permeability transition Circulation 111 2005 194 197 (Pubitemid 40139731)
50. Woodfield K., Ruck A., Brdiczka D., and Halestrap A.P. Direct demonstration of a specific interaction between cyclophilin-D and the adenine nucleotide translocase confirms their role in the mitochondrial permeability transition Biochem J 336 Pt 2 1998 287 290 (Pubitemid 28564382)
51. Oka N., Wang L., Mi W., Zhu W., Honjo O., and Caldarone C.A. Cyclosporine A prevents apoptosis-related mitochondrial dysfunction after neonatal cardioplegic arrest J Thorac Cardiovasc Surg 135 2008 123 130 30 e1-2
52. Spisani S., Fabbri E., and Muccinelli M. Inhibition of neutrophil responses by cyclosporin A. An insight into molecular mechanisms Rheumatology 40 2001 794 800 (Oxford)
53. Ibanez B., and Badimon J.J. Cyclosporine in acute myocardial infarction N Engl J Med 359 2008 2287 author reply 8-9
54. Piot C., Croisille P., and Staat P. Effect of cyclosporine on reperfusion injury in acute myocardial infarction N Engl J Med 359 2008 473 481
55. Burley D.S., Ferdinandy P., and Baxter G.F. Cyclic GMP and protein kinase-G in myocardial ischaemia-reperfusion: opportunities and obstacles for survival signaling Br J Pharmacol 152 2007 855 869 (Pubitemid 350100488)
56. Bogle R., and Wilkins M. Treating acute myocardial infarction: something in the wind? Lancet 370 2007 1461 1462 (Pubitemid 47625543)
57. Hausenloy D.J., and Yellon D.M. New directions for protecting the heart against ischaemia-reperfusion injury: targeting the Reperfusion Injury Salvage Kinase (RISK)-pathway Cardiovasc Res 61 2004 448 460 (Pubitemid 38210151)
58. Hausenloy D.J., and Yellon D.M. Reperfusion injury salvage kinase signalling: taking a RISK for cardioprotection Heart Fail Rev 12 2007 217 234 (Pubitemid 350176695)
59. Hausenloy D.J., Tsang A., and Yellon D.M. The reperfusion injury salvage kinase pathway: a common target for both ischemic preconditioning and postconditioning Trends Cardiovasc Med 15 2005 69 75 (Pubitemid 40693390)
60. Skyschally A., van Caster P., and Boengler K. Ischemic postconditioning in pigs: no causal role for RISK activation Circ Res 104 2009 15 18
61. Bell R.M., and Yellon D.M. Atorvastatin, administered at the onset of reperfusion, and independent of lipid lowering, protects the myocardium by up-regulating a pro-survival pathway J Am Coll Cardiol 41 2003 508 515 (Pubitemid 36164511)
62. Bose A.K., Mocanu M.M., Carr R.D., Brand C.L., and Yellon D.M. Glucagon-like peptide 1 can directly protect the heart against ischemia/reperfusion injury Diabetes 54 2005 146 151 (Pubitemid 40105106)
63. Bullard A.J., Govewalla P., and Yellon D.M. Erythropoietin protects the myocardium against reperfusion injury in vitro and in vivo Basic Res Cardiol 100 2005 397 403 (Pubitemid 41300494)
64. Yang X.M., Philipp S., Downey J.M., and Cohen M.V. Atrial natriuretic peptide administered just prior to reperfusion limits infarction in rabbit hearts Basic Res Cardiol 101 2006 311 318 (Pubitemid 43923387)
65. Bates E., Bode C., and Costa M. Intracoronary KAI-9803 as an adjunct to primary percutaneous coronary intervention for acute ST-segment elevation myocardial infarction Circulation 117 2008 886 896 (Pubitemid 351272586)
66. Zhao Z.Q., Velez D.A., and Wang N.P. Progressively developed myocardial apoptotic cell death during late phase of reperfusion Apoptosis 6 2001 279 290 (Pubitemid 32708522)
67. Saraste A., Pulkki K., Kallajoki M., Henriksen K., Parvinen M., and Voipio-Pulkki L.M. Apoptosis in human acute myocardial infarction Circulation 95 1997 320 323 (Pubitemid 27056193)
68. Mocanu M.M., Baxter G.F., and Yellon D.M. Caspase inhibition and limitation of myocardial infarct size: protection against lethal reperfusion injury Br J Pharmacol 130 2000 197 200 (Pubitemid 30261026)
69. Yaoita H., Ogawa K., Maehara K., and Maruyama Y. Attenuation of ischemia/reperfusion injury in rats by a caspase inhibitor Circulation 97 1998 276 281 (Pubitemid 28067314)
70. Gustafsson A.B., and Gottlieb R.A. Eat your heart out: role of autophagy in myocardial ischemia/reperfusion Autophagy 4 2008 416 421 (Pubitemid 351705137)
71. Matsui Y., Takagi H., and Qu X. Distinct roles of autophagy in the heart during ischemia and reperfusion: roles of AMP-activated protein kinase and Beclin 1 in mediating autophagy Circ Res 100 2007 914 922 (Pubitemid 46555697)
72. Garcia-Dorado D., and Piper H.M. Postconditioning: reperfusion of "reperfusion injury" after hibernation Cardiovasc Res 69 2006 1 3
73. Hausenloy D.J., and Yellon D.M. Preconditioning and postconditioning: united at reperfusion Pharmacol Ther 116 2007 173 191 (Pubitemid 47451505)
74. Hu X., Jiang H., and Ma F. Similarities between ischemic preconditioning and postconditioning in myocardial ischemia/reperfusion injury Int J Cardiol 144 2009 135 136
75. Murry C.E., Jennings R.B., and Reimer K.A. Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 74 1986 1124 1136 (Pubitemid 17174962)
76. Hausenloy D., Wynne A., Duchen M., and Yellon D. Transient mitochondrial permeability transition pore opening mediates preconditioning-induced protection Circulation 109 2004 1714 1717 (Pubitemid 38500671)
77. Li G., Whittaker P., Yao M., Kloner R.A., and Przyklenk K. The gap junction uncoupler heptanol abrogates infarct size reduction with preconditioning in mouse hearts Cardiovasc Pathol 11 2002 158 165 (Pubitemid 34553415)
78. Schwanke U., Konietzka I., Duschin A., Li X., Schulz R., and Heusch G. No ischemic preconditioning in heterozygous connexin43-deficient mice Am J Physiol Heart Circ Physiol 283 2002 H1740 H1742
79. Boengler K., Hilfiker-Kleiner D., Drexler H., Heusch G., and Schulz R. The myocardial JAK/STAT pathway: from protection to failure Pharmacol Ther 120 2008 172 185
80. Smith R.M., Suleman N., and Lacerda L. Genetic depletion of cardiac myocyte STAT-3 abolishes classical preconditioning Cardiovasc Res 63 2004 611 616 (Pubitemid 39078674)
81. Peng C.F., Murphy M.L., Colwell K., and Straub K.D. Controlled versus hyperemic flow during reperfusion of jeopardized ischemic myocardium Am Heart J 117 1989 515 522 (Pubitemid 19078146)
82. Okamoto F., Allen B.S., Buckberg G.D., Bugyi H., and Leaf J. Reperfusion conditions: importance of ensuring gentle versus sudden reperfusion during relief of coronary occlusion J Thorac Cardiovasc Surg 92 1986 613 620 (Pubitemid 16020177)
83. Sato H., Jordan J.E., Zhao Z.Q., Sarvotham S.S., and Vinten-Johansen J. Gradual reperfusion reduces infarct size and endothelial injury but augments neutrophil accumulation Ann Thorac Surg 64 1997 1099 1107 (Pubitemid 27497391)
84. Heusch G. Postconditioning: old wine in a new bottle? J Am Coll Cardiol 44 2004 1111 1112 (Pubitemid 39165148)
85. Tsang A., Hausenloy D.J., Mocanu M.M., and Yellon D.M. Postconditioning: a form of "modified reperfusion" protects the myocardium by activating the phosphatidylinositol 3-kinase-Akt pathway Circ Res 95 2004 230 232 (Pubitemid 39056282)
86. Vinten-Johansen J., Yellon D.M., and Opie L.H. Postconditioning: a simple, clinically applicable procedure to improve revascularization in acute myocardial infarction Circulation 112 2005 2085 2088 (Pubitemid 41475799)
87. Yang X.M., Proctor J.B., Cui L., Krieg T., Downey J.M., and Cohen M.V. Multiple, brief coronary occlusions during early reperfusion protect rabbit hearts by targeting cell signaling pathways J Am Coll Cardiol 44 2004 1103 1110 (Pubitemid 39165147)
88. Laskey W.K. Brief repetitive balloon occlusions enhance reperfusion during percutaneous coronary intervention for acute myocardial infarction: a pilot study Catheter Cardiovasc Interv 65 2005 361 367 (Pubitemid 40898179)
89. Ma X., Zhang X., Li C., and Luo M. Effect of postconditioning on coronary blood flow velocity and endothelial function and LV recovery after myocardial infarction J Interv Cardiol 19 2006 367 375 (Pubitemid 44511065)
90. Ross A.M., Gibbons R.J., Stone G.W., Kloner R.A., and Alexander R.W. A randomized, double-blinded, placebo-controlled multicenter trial of adenosine as an adjunct to reperfusion in the treatment of acute myocardial infarction (AMISTAD-II) J Am Coll Cardiol 45 2005 1775 1780 (Pubitemid 40779856)
91. Kloner R.A., Forman M.B., Gibbons R.J., Ross A.M., Alexander R.W., and Stone G.W. Impact of time to therapy and reperfusion modality on the efficacy of adenosine in acute myocardial infarction: the AMISTAD-2 trial Eur Heart J 27 2006 2400 2405 (Pubitemid 44522145)
92. Schmidt M.R., Smerup M., and Konstantinov I.E. Intermittent peripheral tissue ischemia during coronary ischemia reduces myocardial infarction through a KATP-dependent mechanism: first demonstration of remote ischemic perconditioning Am J Physiol Heart Circ Physiol 292 2007 H1883 H1890
93. Zhao J.L., Yang Y.J., Pei W.D., Sun Y.H., You S.J., and Gao R.L. Remote periconditioning reduces myocardial no-reflow by the activation of K ATP channel via inhibition of Rho-kinase Int J Cardiol 133 2009 179 184
94. Botker H.E., Kharbanda R., and Schmid M.R. Remote ischaemic conditioning before hospital admission, as a complement to angioplasty, and effect on myocardial salvage in patients with acute myocardial infarction: a randomised trial Lancet 375 2010 727 734
95. Chien G.L., Wolff R.A., Davis R.F., and van Winkle D.M. "Normothermic range" temperature affects myocardial infarct size Cardiovasc Res 28 1994 1014 1017
96. Dae M.W., Gao D.W., Sessler D.I., Chair K., and Stillson C.A. Effect of endovascular cooling on myocardial temperature, infarct size, and cardiac output in human-sized pigs Am J Physiol Heart Circ Physiol 282 2002 H1584 H1591
97. Mild therapeutic hypothermia to improve the neurologic outcome after cardiac arrest N Engl J Med 346 2002 549 556
98. Dixon S.R., Whitbourn R.J., and Dae M.W. Induction of mild systemic hypothermia with endovascular cooling during primary percutaneous coronary intervention for acute myocardial infarction J Am Coll Cardiol 40 2002 1928 1934 (Pubitemid 35425362)
99. Ly H.Q., Denault A., and Dupuis J. A pilot study: the Noninvasive Surface Cooling Thermoregulatory System for Mild Hypothermia Induction in Acute Myocardial Infarction (the NICAMI Study) Am Heart J 150 2005 933
100. Opie L.H. Metabolic management of acute myocardial infarction comes to the fore and extends beyond control of hyperglycemia Circulation 117 2008 2172 2177
101. Maroko P.R., Libby P., and Sobel B.E. Effect of glucose-insulin-potassium infusion on myocardial infarction following experimental coronary artery occlusion Circulation 45 1972 1160 1175
102. Opie L.H., Bruyneel K., and Owen P. Effects of glucose, insulin and potassium infusion on tissue metabolic changes within first hour of myocardial infarction in the baboon Circulation 52 1975 49 57
103. Fath-Ordoubadi F., and Beatt K.J. Glucose-insulin-potassium therapy for treatment of acute myocardial infarction: an overview of randomized placebo-controlled trials Circulation 96 1997 1152 1156 (Pubitemid 27344217)
104. Diaz R., Goyal A., and Mehta S.R. Glucose-insulin-potassium therapy in patients with ST-segment elevation myocardial infarction Jama 298 2007 2399 2405 (Pubitemid 350190781)
105. Apstein C.S., and Opie L.H. A challenge to the metabolic approach to myocardial ischaemia Eur Heart J 26 2005 956 959 (Pubitemid 40695025)
106. Nikolaidis L.A., Elahi D., and Hentosz T. Recombinant glucagon-like peptide-1 increases myocardial glucose uptake and improves left ventricular performance in conscious dogs with pacing-induced dilated cardiomyopathy Circulation 110 2004 955 961 (Pubitemid 39128621)
107. Nikolaidis L.A., Mankad S., and Sokos G.G. Effects of glucagon-like peptide-1 in patients with acute myocardial infarction and left ventricular dysfunction after successful reperfusion Circulation 109 2004 962 965 (Pubitemid 38282847)
108. Antman E.M., Hand M., and Armstrong P.W. 2007 Focused Update of the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines: developed in collaboration With the Canadian Cardiovascular Society endorsed by the American Academy of Family Physicians: 2007 Writing Group to Review New Evidence and Update the ACC/AHA 2004 Guidelines for the Management of Patients With ST-Elevation Myocardial Infarction, Writing on Behalf of the 2004 Writing Committee Circulation 117 2008 296 329
109. Sterling D.L., Thornton J.D., and Swafford A. Hyperbaric oxygen limits infarct size in ischemic rabbit myocardium in vivo Circulation 88 1993 1931 1936 (Pubitemid 23296941)
110. Dixon S.R., Bartorelli A.L., and Marcovitz P.A. Initial experience with hyperoxemic reperfusion after primary angioplasty for acute myocardial infarction: results of a pilot study utilizing intracoronary aqueous oxygen therapy J Am Coll Cardiol 39 2002 387 392 (Pubitemid 34117493)
111. Trabattoni D., Bartorelli A.L., and Fabbiocchi F. Hyperoxemic perfusion of the left anterior descending coronary artery after primary angioplasty in anterior ST-elevation myocardial infarction Catheter Cardiovasc Interv 67 2006 859 865 (Pubitemid 43837068)
112. O'Neill W.W., Martin J.L., and Dixon S.R. Acute Myocardial Infarction with Hyperoxemic Therapy (AMIHOT): a prospective, randomized trial of intracoronary hyperoxemic reperfusion after percutaneous coronary intervention J Am Coll Cardiol 50 2007 397 405 (Pubitemid 47088128)
113. Stone G.W., Martin J.L., and de Boer M.J. Effect of supersaturated oxygen delivery on infarct size after percutaneous coronary intervention in acute myocardial infarction Circ Cardiovasc Interv 2 2009 366 375
114. Freemantle N., Cleland J., Young P., Mason J., and Harrison J. beta Blockade after myocardial infarction: systematic review and meta regression analysis Bmj 318 1999 1730 1737 (Pubitemid 29290470)
115. Lopez-Sendon J., Swedberg K., and McMurray J. Expert consensus document on beta-adrenergic receptor blockers Eur Heart J 25 2004 1341 1362
116. Sommers H.M., and Jennings R.B. Ventricular fibrillation and myocardial necrosis after transient ischemia. Effect of treatment with oxygen, procainamide, reserpine, and propranolol Arch Intern Med 129 1972 780 789
117. Roberts R., Croft C., and Gold H.K. Effect of propranolol on myocardial-infarct size in a randomized blinded multicenter trial N Engl J Med 311 1984 218 225 (Pubitemid 14087663)
118. Hjalmarson A., Elmfeldt D., and Herlitz J. Effect on mortality of metoprolol in acute myocardial infarction. A double-blind randomised trial Lancet 2 1981 823 827 (Pubitemid 11017550)
119. Yusuf S., Sleight P., and Rossi P. Reduction in infarct size, arrhythmias and chest pain by early intravenous beta blockade in suspected acute myocardial infarction Circulation 67 1983 I32 I41
120. Risenfors M., Herlitz J., and Berg C.H. Early treatment with thrombolysis and beta-blockade in suspected acute myocardial infarction: results from the TEAHAT Study J Intern Med Suppl 734 1991 35 42
121. Van de Werf F., Janssens L., and Brzostek T. Short-term effects of early intravenous treatment with a beta-adrenergic blocking agent or a specific bradycardiac agent in patients with acute myocardial infarction receiving thrombolytic therapy J Am Coll Cardiol 22 1993 407 416 (Pubitemid 23214552)
122. Halkin A., Grines C.L., and Cox D.A. Impact of intravenous beta-blockade before primary angioplasty on survival in patients undergoing mechanical reperfusion therapy for acute myocardial infarction J Am Coll Cardiol 43 2004 1780 1787 (Pubitemid 38622514)
123. Sharma S.K., Kini A., Marmur J.D., and Fuster V. Cardioprotective effect of prior beta-blocker therapy in reducing creatine kinase-MB elevation after coronary intervention: benefit is extended to improvement in intermediate-term survival Circulation 102 2000 166 172 (Pubitemid 30451772)
124. Kim R.J., Wu E., and Rafael A. The use of contrast-enhanced magnetic resonance imaging to identify reversible myocardial dysfunction N Engl J Med 343 2000 1445 1453
125. Ibanez B., Prat-Gonzalez S., and Speidl W.S. Early metoprolol administration before coronary reperfusion results in increased myocardial salvage: analysis of ischemic myocardium at risk using cardiac magnetic resonance Circulation 115 2007 2909 2916 (Pubitemid 46915384)
126. Heusch G., Skyschally A., Gres P., van Caster P., Schilawa D., and Schulz R. Improvement of regional myocardial blood flow and function and reduction of infarct size with ivabradine: protection beyond heart rate reduction Eur Heart J 29 2008 2265 2275
127. B. Ibanez, G. Cimmino, and S. Prat-Gonzalez The cardioprotection granted by metoprolol is restricted to its administration prior to coronary reperfusion Int J Cardiol 147 2011 428 432
128. Yue T.L., Ma X.L., and Wang X. Possible involvement of stress-activated protein kinase signaling pathway and Fas receptor expression in prevention of ischemia/reperfusion-induced cardiomyocyte apoptosis by carvedilol Circ Res 82 1998 166 174 (Pubitemid 28080099)
129. Morisco C., Marrone C., and Trimarco V. Insulin resistance affects the cytoprotective effect of insulin in cardiomyocytes through an impairment of MAPK phosphatase-1 expression Cardiovasc Res 76 2007 453 464 (Pubitemid 350007455)
130. Ibanez B., Cimmino G., and Badimon J.J. Myocardial reperfusion injury N Engl J Med 357 2007 2409 author reply -10
131. Iwai T., Tanonaka K., Kasahara S., Inoue R., and Takeo S. Protective effect of propranolol on mitochondrial function in the ischaemic heart Br J Pharmacol 136 2002 472 480 (Pubitemid 34620528)
132. Chen Z.M., Pan H.C., and Chen Y.P. Early intravenous then oral metoprolol in 45,852 patients with acute myocardial infarction: randomised placebo-controlled trial Lancet 366 2005 1622 1632
133. H. Park, H. Otani, and C. Oishi Efficacy of intracoronary administration of a short-acting beta-blocker landiolol during reperfusion in pigs Int J Cardiol 146 2011 347 353
134. Rasmussen M.M., Reimer K.A., Kloner R.A., and Jennings R.B. Infarct size reduction by propranolol before and after coronary ligation in dogs Circulation 56 1977 794 798 (Pubitemid 8235184)
135. Hammerman H., Kloner R.A., Briggs L.L., and Braunwald E. Enhancement of salvage of reperfused myocardium by early beta-adrenergic blockade (timolol) J Am Coll Cardiol 3 1984 1438 1443 (Pubitemid 14110099)
136. Reduction of infarct size with the early use of timolol in acute myocardial infarction N Engl J Med 310 1984 9 15
137. Heusch G., Boengler K., and Schulz R. Cardioprotection: nitric oxide, protein kinases, and mitochondria Circulation 118 2008 1915 1919
138. Coats A.J. Ethical authorship and publishing Int J Cardiol 131 2009 149 150